Peptonic launches VagiVital Intimate V Wipes – first pharmacy order
Idag, 10:45
Peptonic launches VagiVital Intimate V Wipes – first pharmacy order
Peptonic Medical AB (publ) (“Peptonic” or “the Company”) announces that its new product, VagiVital Intimate V Wipes, will be launched on the Swedish market in November. The first pharmacy order has already been placed, with delivery scheduled for mid-November. The launch represents a further step in Peptonic’s commercial strategy to broaden the VagiVital product portfolio, strengthen the brand’s market position, and create new sales opportunities within intimate health and self-care.
VagiVital Intimate V Wipes complement the Company’s existing range and have been developed for gentle and practical intimate cleansing. V Wipes are individually wrapped and offer a convenient solution for daily intimate care, whether you’re on the go, at home or travelling. V Wipes contain moisturizing glycerine and a pre- and probiotic complex that helps to support the natural balance of the intimate area.
The launch will initially take place through VagiVital’s own sales channels and pharmacies. By expanding its range with products that meet recurring consumer needs, Peptonic aims to reach new target groups, increase purchase frequency, and create opportunities for increased sales.
“V Wipes is an important addition to our product portfolio and strengthens our offering in daily intimate care. The fact that the first pharmacy order has already been placed ahead of the launch is a positive indication of commercial interest. We see good opportunities to reach more consumers, broaden our distribution and continue to develop VagiVital into a stronger brand within women’s health and wellbeing,” says Daniel Rudeklint, interim CEO of Peptonic Medical AB.
The other two new products previously announced: VagiVital Intimate Moisturizing Cream and the dietary supplement VagiVital Active Balance, will be launched later this autumn.
For further information, please contact:
Daniel Rudeklint
Interim CEO, Peptonic Medical AB
Email:daniel.rudeklint@peptonicmedical.se
Telephone: +46 73 158 02 73
About Peptonic Medical AB
Peptonic Medical AB (publ) is a Swedish company specialising in women’s health that develops and sells products for intimate self-care, health and wellbeing. The company’s strategy is based on developing a broad product portfolio under its own brands, combined with international expansion through strategic distribution and brand partners. Peptonic Medical is listed on the Spotlight Stock Market.
Ämnen i artikeln
Peptonic launches VagiVital Intimate V Wipes – first pharmacy order
Idag, 10:45
Peptonic launches VagiVital Intimate V Wipes – first pharmacy order
Peptonic Medical AB (publ) (“Peptonic” or “the Company”) announces that its new product, VagiVital Intimate V Wipes, will be launched on the Swedish market in November. The first pharmacy order has already been placed, with delivery scheduled for mid-November. The launch represents a further step in Peptonic’s commercial strategy to broaden the VagiVital product portfolio, strengthen the brand’s market position, and create new sales opportunities within intimate health and self-care.
VagiVital Intimate V Wipes complement the Company’s existing range and have been developed for gentle and practical intimate cleansing. V Wipes are individually wrapped and offer a convenient solution for daily intimate care, whether you’re on the go, at home or travelling. V Wipes contain moisturizing glycerine and a pre- and probiotic complex that helps to support the natural balance of the intimate area.
The launch will initially take place through VagiVital’s own sales channels and pharmacies. By expanding its range with products that meet recurring consumer needs, Peptonic aims to reach new target groups, increase purchase frequency, and create opportunities for increased sales.
“V Wipes is an important addition to our product portfolio and strengthens our offering in daily intimate care. The fact that the first pharmacy order has already been placed ahead of the launch is a positive indication of commercial interest. We see good opportunities to reach more consumers, broaden our distribution and continue to develop VagiVital into a stronger brand within women’s health and wellbeing,” says Daniel Rudeklint, interim CEO of Peptonic Medical AB.
The other two new products previously announced: VagiVital Intimate Moisturizing Cream and the dietary supplement VagiVital Active Balance, will be launched later this autumn.
For further information, please contact:
Daniel Rudeklint
Interim CEO, Peptonic Medical AB
Email:daniel.rudeklint@peptonicmedical.se
Telephone: +46 73 158 02 73
About Peptonic Medical AB
Peptonic Medical AB (publ) is a Swedish company specialising in women’s health that develops and sells products for intimate self-care, health and wellbeing. The company’s strategy is based on developing a broad product portfolio under its own brands, combined with international expansion through strategic distribution and brand partners. Peptonic Medical is listed on the Spotlight Stock Market.
Ämnen i artikeln
Aktier
Aktier
Marknadsöversikt
1 DAG %
Senast
1 mån
